|
Anitocabtagene Autoleucel Clinical Trials
1 actively recruiting trial across 1 location
Also known as: CART-ddBCMA
Gilbert, Arizona1 trial
A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma
Banner MD Anderson Cancer Center
Phase 3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.